Printer Friendly

Fisher scientific closes Apogent merger.

Hampton, NH 8/2/04--Fisher Scientific International has completed its merger with Apogent Technologies (see IBO 3/31/04), making Apogent a direct, wholly owned subsidiary. In a tax-free, stock-for-stock exchange, Apogent shareholders received 0.56 shares of Fisher common stock for each share of Apogent stock, which was valued at $32.59 per share based on Fisher's July 30 closing price. The merger is valued at approximately $4 billion. Reflecting the merger closing and its latest outlook, Fisher adjusted guidance for 2004 sales growth to 27.5%-29.5% excluding currency, and to 20.0%-22.0% for 2003. Scientific Products and Services segment revenue is estimated to increase 34%-37%, and Healthcare Products and Services segment revenue is expected to increase 18%-22%. Lab workstation sales are estimated to decline 14%-16%. (For quarterly results from Fisher and Apogent, see page 12.)

Fisher estimates that 74% of its 2004 pro form revenue will be from the scientific research market, 23% from clinical labs and 3% from biopharma production. Proprietary products now account for 60% of the company products and consumables account for 80%. In its conference call, Fisher said it has finalized consolidation plans for corporate administrative functions and integration of manufacturing and distribution locations. It also said that it plans to make more acquisitions in related areas.
COPYRIGHT 2004 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Executive briefing: news, trends & market intelligence for instrument executives
Publication:Instrument Business Outlook
Article Type:Brief Article
Geographic Code:1USA
Date:Aug 15, 2004
Words:220
Previous Article:The 2004 IBO design awards.
Next Article:Grace acquires Alltech.
Topics:


Related Articles
Fisher Scientific increases offer for Perbio.
Fisher and Apogent merge to form $5.1 billion company.
Equipment/distributor index continues to dominate.
2003 instrument industry executive compensation.
Apogent acquires three companies.
Lab distributors reposition for profitability.
Laboratory Equipment/Distribution Index consolidates.
Fisher to divest product line to help win US approval for merger.
FISHER SCIENTIFIC 3RD QTR SALES INCREASED MORE THAN 10%.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters